Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
12.95
+0.78 (6.41%)
Jan 16, 2026, 4:00 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $47.31 billion as of January 16, 2026. Its market cap has increased by 135.02% in one year.
Market Cap
47.31B
Enterprise Value
85.03B
Revenue
53.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.95
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 47.31B, an increase of 707.34%. That is a compound annual growth rate of 6.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 47.31B | 10.61% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |